Answers are grounded in this paper and cite their sources.
Nonribosomal peptide synthetases represent potential platforms for the design and engineering of structurally complex peptides. While previous focus has been centred mainly on bacterial systems, fungal synthetases assembling drugs like the antifungal echinocandins, the antibacterial cephalosporins or the anthelmintic cyclodepsipeptide (CDP) PF1022 await in-depth exploitation. As various mechanistic features of fungal CDP biosynthesis are only partly understood, effective engineering of NRPSs has been severely hampered. By combining protein truncation,
No takes yet. Share an insight, caveat, or question.
Steiniger et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: